Surgical Innovations Group
Surgical Innovations Group PLC is a Leeds-based AIM-listed medical device company that designs, manufactures and distributes reusable-disposable hybrid instruments for minimally invasive surgery, serving NHS trusts, private hospitals and international distributors through its Surgical Innovations Ltd and Elemental Healthcare Ltd subsidiaries.
- Company typePublic
- Founded1987
- HeadquartersLeeds, United Kingdom
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Surgical Innovations Group does
Surgical Innovations Group PLC is a Leeds-based, AIM-listed medical device group (ticker: SUN) that designs, manufactures and distributes instruments for minimally invasive surgery (MIS). Founded in 1987 and listed on AIM in 1998, the group operates through two wholly-owned subsidiaries: Surgical Innovations Ltd, which manufactures the proprietary Resposable® range — a hybrid reusable/disposable instrument concept that the company positions around clinical performance combined with reduced environmental footprint — and Elemental Healthcare Ltd, acquired in July 2017, which distributes third-party and own-label devices to UK NHS trusts and private hospitals.
The core product portfolio includes CE-marked YelloPort Elite surgical access ports, the Cellis surgical range (including Cellis Breast), and distribution rights for the Distalmotion Dexter laparoscopic robot. The group also offers Engineering, Manufacturing and OEM services, R&D, Regulatory and Quality (MDR transition) and Supply Chain/Logistics capabilities to external partners. Revenue is generated through three streams: direct hardware sales of own-brand devices, third-party distribution via Elemental Healthcare's NHS framework agreements, and OEM/professional services for partner-manufactured devices.
Commercial reach spans the United Kingdom — the primary market, with over 60% of Elemental Healthcare sales flowing through NHS framework agreements including the newly awarded MIS3 framework starting August 2026 — alongside distribution agreements covering the United States, Europe, the Middle East, Brazil, Mexico and Singapore. The group is pursuing expansion into robotic-assisted MIS via partnerships with CMR Surgical (March 2022) and Distalmotion, while operating under an ESG framework targeting NetZero Scope 1 and 2 emissions by 2030 and Scope 3 by 2040.
Surgical Innovations Group firmographics
Firmographics- Name
- Surgical Innovations Group
- Legal name
- Surgical Innovations Group PLC
- Website
- https://sigroupplc.com
- Company type
- Public
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Surgical Innovations Group PLC is a Leeds-based AIM-listed medical device company that designs, manufactures and distributes reusable-disposable hybrid instruments for minimally invasive surgery, serving NHS trusts, private hospitals and international distributors through its Surgical Innovations Ltd and Elemental Healthcare Ltd subsidiaries.
- Ownership category
- akta.pro rank
Surgical Innovations Group industry classification
Industry- Product category
- Minimally Invasive Surgical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)
- akta.pro secondary industries
- Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM), Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG)
Keywords
Where Surgical Innovations Group is headquartered
LocationHeadquarters
- HQ city
- Leeds
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Surgical Innovations Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: Sale of surgical equipment and medical devices for minimally invasive surgery to healthcare providers including NHS trusts, private hospitals, and international customers through direct sales and distribution network.
- Distribution Services: Revenue from distributing third-party medical devices through Elemental Healthcare's established NHS framework agreements and distribution network.
- OEM/Manufacturing Services: Engineering, manufacturing and OEM services providing custom medical device manufacturing solutions for partners and clients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Multi-year contract | NHS Framework Pricing |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Surgical Innovations Group product offering
Product offeringCore offering
Surgical Innovations Group PLC designs, manufactures and distributes medical devices and instruments for minimally invasive (laparoscopic) surgery. Core output includes the proprietary Resposable® range of hybrid reusable/disposable surgical instruments, CE-certified access ports (YelloPort Elite) and the Cellis range of surgical devices. The group also provides OEM/contract manufacturing, R&D, regulatory/quality, and supply chain & logistics services to medical device partners via its manufacturing subsidiary Surgical Innovations Ltd and UK NHS distribution subsidiary Elemental Healthcare Ltd.
Product overview
Surgical Innovations Group is a medical device manufacturer operating as a platform of integrated businesses. The Group comprises Surgical Innovations Ltd (core surgical instrument brand), Elemental Healthcare Ltd (NHS-focused distribution subsidiary), and service divisions covering Engineering/Manufacturing/OEM, R&D, Regulatory & Quality, and Supply Chain & Logistics. The core product focus is on sustainable minimally invasive surgery (MIS) solutions, with the Resposable range combining reusable and disposable elements. Key product lines include YelloPort Elite surgical access ports and the Cellis range. The Group also distributes third-party products including the Distalmotion Dexter surgical robot. Elemental Healthcare operates NHS framework agreements (including MIS3) providing access to NHS Supply Chain procurement channels.
Differentiator
Problem solved
Functional benefit
Brands
- Resposable: Sustainable product range combining reusable and disposable elements for minimally invasive surgery, designed to reduce environmental footprint while maintaining clinical performance
- Yelloport Elite
- Elemental Healthcare
- Engineering, Manufacturing & OEM
Quantifiable outcome
- 12.1% absolute energy consumption reduction between 2022 and 2023
- +1 more outcomes
Companies that use Surgical Innovations Group
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Surgical Innovations Group technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Surgical Innovations Group partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core, strategic and minor.
- NHS Supply ChaincoreElemental Healthcare Ltd, a subsidiary of Surgical Innovations Group, has been awarded a place on the NHS Minimally Invasive Surgery 3 (MIS3) framework agreement for a two-year period starting August 10, 2026. The framework provides access to NHS procurement channels through NHS Supply Chain for NHS trusts across the UK.
- CMR SurgicalstrategicProduct launch partnership announced in March 2022 for integration of Surgical Innovations products with CMR Surgical's surgical robotics platform.
- UK Distribution Partnerscore3-year exclusive UK distribution agreement for specified surgical products and territories.
- US Distribution Partnerscore5-year USA distribution agreement for US market coverage.
- US Distribution PartnerscoreNationwide US distribution agreement established for distribution of surgical products across the United States market.
- Centre For Sustainable HealthcareminorCollaboration on sustainable healthcare initiatives and green surgery challenges.
- Medilink UKminorSurgical Innovation Ltd (subsidiary) utilized Medilink UK's International Market Access services for expansion into Brazil, Mexico, and Singapore markets, utilizing services covering market segmentation, regulatory documentation, and reimbursement pathways.
Scale indicators8 records
Recent moves7 records
Expansion highlights5 records
Surgical Innovations Group competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Surgical Innovations Group social profiles
Digital presenceSurgical Innovations Group compliance and trust
Trust signalCompliance3 records
Surgical Innovations Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Surgical Innovations Group leadership team
Management profileNumber of profiles
Profiles7 records
Surgical Innovations Group subsidiaries and ownership
Company hierarchySubsidiaries2 records
Surgical Innovations Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Surgical Innovations Group M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Surgical Innovations Group
What does Surgical Innovations Group do?
Surgical Innovations Group PLC designs, manufactures and distributes medical devices and instruments for minimally invasive (laparoscopic) surgery. Core output includes the proprietary Resposable® range of hybrid reusable/disposable surgical instruments, CE-certified access ports (YelloPort Elite) and the Cellis range of surgical devices. The group also provides OEM/contract manufacturing, R&D, regulatory/quality, and supply chain & logistics services to medical device partners via its manufacturing subsidiary Surgical Innovations Ltd and UK NHS distribution subsidiary Elemental Healthcare Ltd.
Is Surgical Innovations Group a public or private company?
Surgical Innovations Group is a public company. It is classified as public and is currently operating.
When was Surgical Innovations Group founded?
Surgical Innovations Group was founded in 1987. It employs 51 to 100 people.
Where is Surgical Innovations Group based?
Surgical Innovations Group is headquartered in Leeds, United Kingdom, in the Europe region.
How does Surgical Innovations Group make money?
Three revenue lines are on record. Medical Device Sales are the primary driver. The others are distribution Services and OEM/Manufacturing Services.
Does Surgical Innovations Group have an API?
No public API is recorded for Surgical Innovations Group.
What industry is Surgical Innovations Group in?
Surgical Innovations Group's product category is Minimally Invasive Surgical Devices. Its primary akta.pro industry code is HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS), with a secondary code of HLAHADAM, Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits). Its NAICS code is 339112 and its SIC code is 3841.